These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6733704)

  • 21. Phase I trial of mitoxantrone by 24-hour continuous infusion.
    Anderson KC; Garnick MB; Meshad MW; Cohen GI; Pegg WJ; Frei E; Israel M; Modest E; Canellos GP
    Cancer Treat Rep; 1983 May; 67(5):435-8. PubMed ID: 6850662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of metastatic sarcomas with mitoxantrone.
    Presant CA; Gams R; Bartolucci AA
    Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase I study of a 5-day schedule of mitoxantrone (dihydroxyanthracenedione).
    Wynert WR; Harvey HA; Lipton A; Schweitzer J; White DS
    Cancer Treat Rep; 1982 Jun; 66(6):1303-6. PubMed ID: 7083234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High-dose Roncoleukin in patients with disseminated cutaneous melanoma: a phase 1 study].
    Moiseenko VM; Novik AV; Orlova RV; Protsenko SA; Mikhaĭlichenko TD; Semenova AI; Tiukavina NV
    Vopr Onkol; 2005; 51(5):546-9. PubMed ID: 16756008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
    Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
    Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group report.
    Van Amburg AL; Presant CA; Burns D
    Cancer Treat Rep; 1982 Jun; 66(6):1431-3. PubMed ID: 6211234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Bartolucci A
    Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.
    Glaspy J; Atkins MB; Richards JM; Agarwala SS; O'Day S; Knight RD; Jungnelius JU; Bedikian AY
    Cancer; 2009 Nov; 115(22):5228-36. PubMed ID: 19728370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
    Markovic SN; Geyer SM; Dawkins F; Sharfman W; Albertini M; Maples W; Fracasso PM; Fitch T; Lorusso P; Adjei AA; Erlichman C
    Cancer; 2005 Jun; 103(12):2584-9. PubMed ID: 15887220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
    Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
    Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential cardiotoxicity with mitoxantrone.
    Schell FC; Yap HY; Blumenschein G; Valdivieso M; Bodey G
    Cancer Treat Rep; 1982 Aug; 66(8):1641-3. PubMed ID: 7105054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of mitoxantrone in patients with primary liver cancer.
    Falkson G; Coetzer BJ; Terblanche AP
    Cancer Treat Rep; 1984 Oct; 68(10):1311-2. PubMed ID: 6525607
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase I trial of mitoxantrone in children.
    Ungerleider RS; Pratt CB; Vietti TJ; Holcenberg JS; Kamen BA; Glaubiger DL; Cohen LF
    Cancer Treat Rep; 1985 Apr; 69(4):403-7. PubMed ID: 3857968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of mitoxantrone.
    Anderson KC; Cohen GI; Garnick MB
    Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinoma.
    DeSimone PA; Gams R; Bartolucci A
    Am J Clin Oncol; 1984 Oct; 7(5):517-22. PubMed ID: 6507372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adjuvant drug therapy of malignant melanoma. Current knowledge and multi-center studies in German-speaking countries].
    Hauschild A; Volkenandt M; Garbe C
    Dtsch Med Wochenschr; 2000 Oct; 125(42):1272-8. PubMed ID: 11098240
    [No Abstract]   [Full Text] [Related]  

  • 38. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Ehninger G; Ho AD; Meyer P; Mjaaland I; Ostendorf P; Seither E
    Onkologie; 1985 Jun; 8(3):146-8. PubMed ID: 3895096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
    Hancock BW; Wheatley K; Harris S; Ives N; Harrison G; Horsman JM; Middleton MR; Thatcher N; Lorigan PC; Marsden JR; Burrows L; Gore M
    J Clin Oncol; 2004 Jan; 22(1):53-61. PubMed ID: 14665609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
    Rudolf Z; Strojan P
    Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.